|
|
|
41
|
0112CN
|
ZINNAT 50MG/ML SUSP (BCH) CEFUROXIME
|
CEFUROXIME
|
ZINNAT
|
100ML
|
BQ
|
22.67
|
0.2267
|
ML
|
60
|
BOTT
|
BCH
|
SANDOZ
|
COL
|
COLLINS LTD
|
|
08120608
|
SECOND GEN CEPHALOSPORINS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
SECOND GEN CEPHALOSPORINS
|
2023-08-10
|
|
|
|
40
|
0112ZG
|
ZINNAT 25MG/ML SUSP (GSK/COL) CEFUROXIME
|
CEFUROXIME
|
ZINNAT
|
100ML
|
C
|
28.11
|
0.28
|
SUSPENSION
|
0
|
ML
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
08120608
|
SECOND GEN CEPHALOSPORINS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
0112ZG
|
ZINNAT 25MG/ML SUSP (GSK) CEFUROXIME
|
CEFUROXIME
|
ZINNAT
|
100ML
|
BQ
|
25.66
|
0.2566
|
ML
|
21
|
BOTT
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
08120608
|
SECOND GEN CEPHALOSPORINS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
SECOND GEN CEPHALOSPORINS
|
|
|
|
|
40
|
01133
|
CEFAZOLIN 1G IV/IM INJ (RTM/PHA)
|
CEFAZOLIN
|
CEFAZOLIN
|
1G VIAL
|
B
|
3.89
|
3.89
|
INJECTION
|
0
|
VIAL
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
08120604
|
FIRST GEN CEPHALOSPORINS
|
2022-04-01
|
2024-03-31
|
|
IV/IM
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
01133
|
CEFAZOLIN 1G IV/IM INJ (RTM) (BQ)
|
CEFAZOLIN
|
CEFAZOLIN
|
1G VIAL
|
BQ
|
3.97
|
3.9688
|
VIAL
|
10
|
VIAL
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
08120604
|
FIRST GEN CEPHALOSPORINS
|
2024-04-01
|
2026-03-31
|
|
IV/IM
|
0
|
FIRST GEN CEPHALOSPORINS
|
|
|
|
|
40
|
0113AG
|
CEFAZOLIN 1G IV/IM INJ (KWA/ATB)
|
CEFAZOLIN
|
CEFAZOLIN
|
1G VIAL
|
B
|
4.02
|
4.02
|
INJECTION
|
0
|
VIAL
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
08120604
|
FIRST GEN CEPHALOSPORINS
|
2022-04-01
|
2022-09-30
|
|
IV/IM
|
0
|
ANTI-INFECTIVE AGENTS
|
2022-03-30
|
|
|
|
41
|
0113BA
|
CEFAZOL 1G INJ (INC) (BQ)
|
CEFAZOLIN
|
CEFAZOL
|
15ML VIAL
|
BQ
|
14.19
|
14.1897
|
VIAL
|
0
|
VIAL
|
INC
|
INCEPTA PHARMACEUTICALS LIMITED
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08120604
|
FIRST GEN CEPHALOSPORINS
|
2024-04-01
|
2026-03-31
|
|
IV/IM
|
0
|
FIRST GEN CEPHALOSPORINS
|
|
|
|
|
41
|
0113G
|
ALCOVERA 1G INJ (UNI) CEFAZOLIN (BQ)
|
CEFAZOLIN
|
ALCOVERA
|
1G VIAL
|
BQ
|
4.46
|
4.4581
|
VIAL
|
0
|
VIAL
|
UNI
|
UNIQUE PHARMACEUTICAL LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08120612
|
THIRD GEN CEPHALOSPORINS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
THIRD GEN CEPHALOSPORINS
|
|
|
|
|
40
|
0114BP
|
ALTACEF 250MG TAB (GLP/ATB) CEFUROXIME
|
CEFUROXIME
|
ALTACEF
|
10'S
|
BQ
|
4.08
|
0.41
|
TABLET
|
0
|
TAB
|
GLP
|
GLENMARK PHARMACEUTICALS LTD
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
08120608
|
SECOND GEN CEPHALOSPORINS
|
2022-04-01
|
2024-03-31
|
Change Local Agent
|
Oral
|
6
|
ANTI-INFECTIVE AGENTS
|
2022-03-22
|
|
|
|
40
|
0114BT
|
ZINNAT 250MG TAB (BCH) CEFUROXIME
|
CEFUROXIME
|
ZINNAT 250MG TAB
|
50'S
|
C
|
$97.23
|
1.94
|
TABLET
|
|
TAB
|
BCH
|
SANDOZ USA
|
COL
|
COLLINS LIMITED
|
|
08120608
|
SECOND GEN CEPHALOSPORINS
|
0000-00-00
|
0000-00-00
|
CONTRACT AWARDED CAT C
|
ORAL
|
|
ANTI-INFECTIVE AGENTS
|
0000-00-00
|
|
|
|
41
|
0114BT
|
ZINNAT 250MG TAB (BCH) CEFUROXIME
|
CEFUROXIME
|
ZINNAT
|
50'S
|
BQ
|
32.46
|
0.6492
|
TAB
|
28
|
BOX
|
BCH
|
SANDOZ
|
COL
|
COLLINS LTD
|
|
08120608
|
SECOND GEN CEPHALOSPORINS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
SECOND GEN CEPHALOSPORINS
|
2023-08-10
|
|
|
|
40
|
0114L
|
ZINNAT 250MG TAB (GSK/COL) CEFUROXIME
|
CEFUROXIME
|
ZINNAT
|
50'S
|
C
|
97.07
|
1.94
|
TABLET
|
0
|
TAB
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
08120608
|
SECOND GEN CEPHALOSPORINS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
01243
|
OPTOMYCIN 0.5% EYE DR (ASL/PHA) CHLORAMPHENIC
|
CHLORAMPHENICOL
|
OPTOMYCIN
|
10ML
|
C
|
4.08
|
4.08
|
EYE DROP
|
0
|
BOTT
|
ASL
|
ASHFORD LABORATORIES LTD
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
520404
|
EENT ANTIBACTERIALS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
40
|
0124N
|
CHLORAMPHENICOL 0.5% EYE DR (MTP/COL)
|
CHLORAMPHENICOL
|
CHLORAMPHENICOL
|
10ML
|
C
|
2.58
|
2.58
|
EYE DROP
|
0
|
BOTT
|
MTP
|
MARTINDALE PHARMACEUTICALS
|
COL
|
COLLINS LTD
|
|
520404
|
EENT ANTIBACTERIALS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
40
|
0124R
|
CHLORAMPHENICOL 0.5% EYE DR (CIR/AHI)
|
CHLORAMPHENICOL
|
CHLORAMPHENICOL
|
10ML
|
A
|
1.90
|
1.90
|
EYE DROP
|
1
|
BOTT
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
520404
|
EENT ANTIBACTERIALS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
0124R
|
CHLORAMPHENICOL 0.5% EYE DR (CIR)
|
CHLORAMPHENICOL
|
CHLORAMPHENICOL
|
10ML
|
A
|
2.07
|
2.0659
|
BOTT
|
1
|
BOTT
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
520404
|
EENT ANTIBACTERIALS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
0
|
EENT ANTIBACTERIALS
|
|
|
|
|
40
|
0124V
|
CHLORAMPHENICOL 0.5% EYE DR (FSB/ATB)
|
CHLORAMPHENICOL
|
CHLORAMPHENICOL
|
10ML
|
A
|
1.60
|
1.60
|
EYE DROP
|
1
|
BOTT
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
520404
|
EENT ANTIBACTERIALS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
0124V
|
CHLORAMPHENICOL 0.5% EYE DR (FSB)
|
CHLORAMPHENICOL
|
CHLORAMPHENICOL
|
10ML
|
A
|
1.66
|
1.6582
|
BOTT
|
1
|
BOTT
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
520404
|
EENT ANTIBACTERIALS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
0
|
EENT ANTIBACTERIALS
|
|
|
|
|
41
|
0124Y
|
OPTICHLOR 0.5% EYE DR (SHC) CHLORAMPHENICOL
|
CHLORAMPHENICOL
|
OPTICHLOR
|
10ML
|
A
|
2.61
|
2.6096
|
BOTT
|
1
|
BOTT
|
SHC
|
SION HEALTHCARE
|
PSB
|
PHARMACEUTICAL SOLUTIONS BARBA
|
|
520404
|
EENT ANTIBACTERIALS
|
2024-04-01
|
2024-08-01
|
|
OPHTHALMIC
|
0
|
EENT ANTIBACTERIALS
|
2024-06-20
|
|
|
|
40
|
0125J
|
CHLORAMPHENICOL 1% EYE OINT (MTP/COL)
|
CHLORAMPHENICOL
|
CHLORAMPHENICOL
|
4G
|
A
|
4.21
|
4.21
|
EYE OINTMENT
|
1
|
TUBE
|
MTP
|
MARTINDALE PHARMACEUTICALS
|
COL
|
COLLINS LTD
|
|
520404
|
EENT ANTIBACTERIALS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|